A new cancer drug candidate has demonstrated the ability to block tumor growth without triggering a common and debilitating ...

The high frequency of mutations in cancer cells which result in altered cell cycle regulation and growth signal transduction, conferring a proliferative advantage, indicates that many of these ...

University of South Alabama researchers report that neurons can transfer mitochondria directly to cancer cells, enhancing ...

The new nCounter Tumor Signaling 360 gene expression panel homes in on signaling pathways involved in the sustained growth and maintenance of tumor cells while providing a holistic view of the immune ...

In diseases due to exposure to toxic particles like gout, macrophages elicit separate pathways for inflammation and lysosomal ...

Amgen acquired Five Prime in 2021 on the back of the phase 2 FIGHT trial of bemarituzumab, which achieved significant ...

A rare cell in the lining of lungs is fundamental to the organwide response necessary to repair damage from toxins like those in wildfire smoke or ...

A new cancer drug candidate developed by Lawrence Livermore National Laboratory, BridgeBio Oncology Therapeutics and ...

RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

In 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths worldwide, according to the World ...

A recent study published in Genes & Diseases has unveiled a novel mechanism by which the restriction of YWHAB-mediated YAP cytoplasmic retention plays ...